Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Friebe

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
The Journal of Physiology|September 11, 2013
Correlation of cellular expression with function of NO-sensitive guanylyl cyclase in the murine lower urinary tractBarbara Lies, Dieter Groneberg, Andreas Friebe
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 25, 2018
Correction to: Meeting report of the 8<sup>th</sup> International Conference on "cGMP BcGMP: generators, effectors, and therapeutic implications" at Bamberg, Germany, from June 23 to 25, 2017Andreas Friebe, Peter Sandner, Achim Schmidtko
Molecular Biology of the Cell|July 9, 2004
In vivo reconstitution of the negative feedback in nitric oxide/cGMP signaling: role of phosphodiesterase type 5 phosphorylationFlorian Mullershausen, Michael Russwurm, Doris Koesling, et al.
Gastroenterology|February 1, 2011
Nitric oxide-sensitive guanylyl cyclase is dispensable for nitrergic signaling and gut motility in mouse intestinal smooth muscleDieter Groneberg, Peter König, Doris Koesling, et al.
Circulation|April 7, 2004
Inhibition of phosphodiesterase type 5 by the activator of nitric oxide-sensitive guanylyl cyclase BAY 41-2272Florian Mullershausen, Michael Russwurm, Andreas Friebe, et al.
British Journal of Pharmacology|June 15, 2013
Lack of effect of ODQ does not exclude cGMP signalling via NO-sensitive guanylyl cyclaseBarbara Lies, Dieter Groneberg, Stepan Gambaryan, et al.
Vascular Pharmacology|September 19, 2003
The enhanced NO-induced cGMP response induced by long-term L-NAME treatment is not due to enhanced expression of NO-sensitive guanylyl cyclaseFlorian Müllershausen, Michael Russwurm, Doris Koesling, et al.
The Journal of Biological Chemistry|March 8, 2005
Dimerization of nitric oxide-sensitive guanylyl cyclase requires the alpha 1 N terminusCorina Wagner, Michael Russwurm, Ronald Jäger, et al.
The Journal of Clinical Investigation|April 15, 2006
Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular systemEvanthia Mergia, Andreas Friebe, Oliver Dangel, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2007
Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide-sensitive guanylyl cyclaseAndreas Friebe, Evanthia Mergia, Oliver Dangel, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
The Journal of Physiology|September 11, 2013
Correlation of cellular expression with function of NO-sensitive guanylyl cyclase in the murine lower urinary tractBarbara Lies, Dieter Groneberg, Andreas Friebe
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 25, 2018
Correction to: Meeting report of the 8<sup>th</sup> International Conference on "cGMP BcGMP: generators, effectors, and therapeutic implications" at Bamberg, Germany, from June 23 to 25, 2017Andreas Friebe, Peter Sandner, Achim Schmidtko
Molecular Biology of the Cell|July 9, 2004
In vivo reconstitution of the negative feedback in nitric oxide/cGMP signaling: role of phosphodiesterase type 5 phosphorylationFlorian Mullershausen, Michael Russwurm, Doris Koesling, et al.
Gastroenterology|February 1, 2011
Nitric oxide-sensitive guanylyl cyclase is dispensable for nitrergic signaling and gut motility in mouse intestinal smooth muscleDieter Groneberg, Peter König, Doris Koesling, et al.
Circulation|April 7, 2004
Inhibition of phosphodiesterase type 5 by the activator of nitric oxide-sensitive guanylyl cyclase BAY 41-2272Florian Mullershausen, Michael Russwurm, Andreas Friebe, et al.
British Journal of Pharmacology|June 15, 2013
Lack of effect of ODQ does not exclude cGMP signalling via NO-sensitive guanylyl cyclaseBarbara Lies, Dieter Groneberg, Stepan Gambaryan, et al.
Vascular Pharmacology|September 19, 2003
The enhanced NO-induced cGMP response induced by long-term L-NAME treatment is not due to enhanced expression of NO-sensitive guanylyl cyclaseFlorian Müllershausen, Michael Russwurm, Doris Koesling, et al.
The Journal of Biological Chemistry|March 8, 2005
Dimerization of nitric oxide-sensitive guanylyl cyclase requires the alpha 1 N terminusCorina Wagner, Michael Russwurm, Ronald Jäger, et al.
The Journal of Clinical Investigation|April 15, 2006
Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular systemEvanthia Mergia, Andreas Friebe, Oliver Dangel, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2007
Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide-sensitive guanylyl cyclaseAndreas Friebe, Evanthia Mergia, Oliver Dangel, et al.
Pageof 8